Comparing outcomes of ILD patients managed in specialised versus non-specialised centres

Early appropriate diagnosis and treatment of interstitial lung diseases (ILD) is crucial to slow disease progression and improve survival. Yet it is unknown whether initial management in an expert centre is associated with improved outcomes. Therefore, we assessed mortality, hospitalisations and hea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Marijic, Pavo (VerfasserIn) , Schwarzkopf, Larissa (VerfasserIn) , Maier, Werner Albert (VerfasserIn) , Trudzinski, Franziska (VerfasserIn) , Kreuter, Michael (VerfasserIn) , Schwettmann, Lars (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 August 2022
In: Respiratory research
Year: 2022, Jahrgang: 23, Pages: 1-12
ISSN:1465-993X
DOI:10.1186/s12931-022-02143-1
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12931-022-02143-1
Resolving-System, kostenfrei: https://doi.org/10.25673/117297
Volltext
Verfasserangaben:Pavo Marijic, Larissa Schwarzkopf, Werner Maier, Franziska Trudzinski, Michael Kreuter and Lars Schwettmann
Beschreibung
Zusammenfassung:Early appropriate diagnosis and treatment of interstitial lung diseases (ILD) is crucial to slow disease progression and improve survival. Yet it is unknown whether initial management in an expert centre is associated with improved outcomes. Therefore, we assessed mortality, hospitalisations and health care costs of ILD patients initially diagnosed and managed in specialised ILD centres versus non-specialised centres and explored differences in pharmaceutical treatment patterns.
Beschreibung:Gesehen am 15.09.2022
Beschreibung:Online Resource
ISSN:1465-993X
DOI:10.1186/s12931-022-02143-1